SureTrader
Home > Boards > US Listed > Medical - Drugs > Valeant Pharmaceuticals International (VRX)

IMHO, a 15% drop is way too much.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
JLS Member Profile
 
Followed By 49
Posts 6,285
Boards Moderated 0
Alias Born 12/14/04
160x600 placeholder
Ortho Dermatologics Presents An Analysis Of SILIQ™ (Brodalumab) Injection Phase 3 Data On Disease-Related Anxiety And Depre... PR Newswire (Canada) - 2/16/2018 10:00:00 AM
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For JEMDEL™ Plaque Psoriasis Treatment PR Newswire (Canada) - 2/14/2018 7:00:00 AM
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For JEMDEL™ Plaque Psoriasis Treatment PR Newswire (US) - 2/14/2018 7:00:00 AM
Salix Provides Update on FDA Submission for PLENVU®* PR Newswire (Canada) - 2/9/2018 9:10:00 AM
Salix Provides Update on FDA Submission for PLENVU®* PR Newswire (US) - 2/9/2018 9:10:00 AM
Investment Opportunities in Advanced Bioengineered Drug Delivery NetworkNewsWire - 2/7/2018 8:45:00 AM
Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28 PR Newswire (Canada) - 2/6/2018 10:25:00 AM
Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28 PR Newswire (US) - 2/6/2018 10:25:00 AM
VRX Investor Alert: Kyros Law Files Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors PR Newswire (US) - 1/30/2018 7:05:00 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 1/29/2018 10:33:33 AM
Valeant Will Reduce Debt By An Additional $200 Million PR Newswire (Canada) - 1/25/2018 3:02:00 PM
Valeant Will Reduce Debt By An Additional $200 Million PR Newswire (US) - 1/25/2018 3:02:00 PM
Allergan Pact Advances -- WSJ Dow Jones News - 1/17/2018 3:02:00 AM
Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant -- Update Dow Jones News - 1/16/2018 6:32:00 PM
Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant Dow Jones News - 1/16/2018 5:09:00 PM
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form PR Newswire (Canada) - 1/12/2018 7:00:00 AM
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form PR Newswire (US) - 1/12/2018 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/9/2018 3:31:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/9/2018 3:28:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/9/2018 3:26:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/9/2018 10:05:55 AM
Valeant Provides Company Update At The 36th Annual J.P. Morgan Healthcare Conference PR Newswire (Canada) - 1/9/2018 7:00:00 AM
Valeant Provides Company Update At The 36th Annual J.P. Morgan Healthcare Conference PR Newswire (US) - 1/9/2018 7:00:00 AM
Bausch + Lomb Receives CE Mark From The European Commission For The Stellaris Elite™ Vision Enhancement System, Including T... PR Newswire (US) - 1/8/2018 8:00:00 AM
Bausch + Lomb Receives CE Mark From The European Commission For The Stellaris Elite™ Vision Enhancement System, Including T... PR Newswire (Canada) - 1/8/2018 8:00:00 AM
JLS   Thursday, 11/09/17 04:26:01 PM
Re: JohnCM post# 3869
Post # of 4363 
IMHO, a 15% drop is way too much.

The catastrophe that would cause VRX to go back 15% is a bear market.

Given that a bear market is not on the horizon; IMO a 15% drop in VRX is not where you should stop out of your position. That is where you should double down on your position.

At this point I think it is reasonable for VRX to trade around the $16.50 to $17.50 area as it did last July.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist